| p21(Waf1) can be indispensable for complete oncogenic transformation. | None |
| The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding. | None |
| A mouse model to identify cooperating signaling pathways in cancer. | None |
| In large airway epithelium of smokers with and without COPD, the cytoplasmic p21 inhibits cell apoptosis, promotes cell proliferation and correlates with squamous cell metaplasia thus representing a potential pre-oncogenic hallmark | None |
| The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation. | None |
| Identification of an intracellular protein that specifically interacts with photoaffinity-labeled oncogenic p21 protein. | None |
| Induction of T cells specific for the mutated segment of oncogenic P21ras protein by immunization in vivo with the oncogenic protein. | None |
| Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein. | None |
| Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. | None |
| A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. | None |